News

Filter

Current filters:

Cardio-vascular

101 to 110 of 97252 results

Added benefit of Eylea over Lucentis in DME not proven, says IQWiG

Added benefit of Eylea over Lucentis in DME not proven, says IQWiG

16-12-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) has compared trial data on German…

BayerEyleaGermanyLucentisNovartisOphthalmicsPharmaceuticalPricingRegulationRoche

UK NICE partially backs Bayer’s Xofigo in preliminary assessment

UK NICE partially backs Bayer’s Xofigo in preliminary assessment

15-12-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) have recommended…

BayerOncologyPharmaceuticalPricingRegulationUKXofigo

OPKO Health leaps on potential $570 million deal with Pfizer

OPKO Health leaps on potential $570 million deal with Pfizer

15-12-2014

US drugmaker OPKO Health saw its shares leap 13.8% in pre-market trading, when it revealed a licensing…

LicensingOPKO HealthPfizerPharmaceuticalRare diseasesUSA

Sorrento to partner with Nantworks founder Patrick Soon-Shiong on immunomodulatory antibodies

Sorrento to partner with Nantworks founder Patrick Soon-Shiong on immunomodulatory antibodies

15-12-2014

Oncology specialist Sorrento Therapeutics has entered into a binding agreement with medical technology…

BiotechnologyLicensingOncologyResearchSorrento TherapeuticsUSA

Genentech files NDA for cobimetinib with Zelboraf in advanced melanoma

Genentech files NDA for cobimetinib with Zelboraf in advanced melanoma

15-12-2014

Genentech, the US biotech subsidiary of Swiss Pharma major Roche Group, has submitted a New Drug Application…

BiotechnologycobimetinibExelixisGenentechOncologyRegulationRocheUSAZelboraf

Gilead appoints Philippe Bishop as senior vice president of hematology and oncology therapeutics

Gilead appoints Philippe Bishop as senior vice president of hematology and oncology therapeutics

15-12-2014

US biotech major Gilead Sciences has appointed Philippe Bishop as senior vice president of hematology…

BiotechnologyBoardroomGilead SciencesHematologyOncologyUSA

Ignyta and Nerviano amend license accord on entrectinib

Ignyta and Nerviano amend license accord on entrectinib

15-12-2014

US oncology focused biotech firm Ignyta has agreed to an amendment to its license agreement with Italy’s…

BiotechnologyentrectinibIgnytaLicensingNerviano Medical SciencesOncologyRXDX-101

Immune Pharmaceuticals appoints Daniel Kazado chairman of the board

Immune Pharmaceuticals appoints Daniel Kazado chairman of the board

15-12-2014

US-Israeli company Immune Pharmaceuticals has appointed Daniel Kazado chairman of the board, succeeding…

BoardroomImmune PharmaceuticalsIsraelPharmaceuticalUSA

Co-founder Joost Holthuis replaces founder as chief executive amid $7 million financing round

Co-founder Joost Holthuis replaces founder as chief executive amid $7 million financing round

15-12-2014

The co-founder of Dutch nanomedicine company Cristal Therapeutics, Joost Holthuis, has succeeded its…

BioGeneration VenturesBiotechnologyBoardroomCristal TherapeuticsNetherlands

101 to 110 of 97252 results

Back to top